CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11,947.7% | – | -8,258.8% | -11,940.9% | – | – | -24,501.9% | -8,327.0% | -77,425.2% | -1,507.9% | -1,161.8% | -375.0% | -1,002.3% | |
| 78.9% | – | 74.1% | 188.7% | – | – | 256.2% | 93.0% | 707.7% | 16.1% | 10.8% | 4.3% | 10.1% | |
| 3,193.4% | – | 2,102.2% | 4,746.9% | – | – | 5,672.6% | 2,533.9% | 15,875.5% | 352.5% | 276.5% | 99.1% | 234.8% | |
| 1,402.9% | – | 420.6% | 2,349.9% | – | – | -2,641.8% | 640.3% | -1,045.5% | 150.5% | -244.1% | 8.2% | -38.8% | |
| 1,011.6% | – | 208.1% | 239.3% | – | – | 343.2% | 310.6% | 603.5% | 7.4% | 7.6% | 2.1% | 6.3% | |
| -55,865.9% | – | 48.3% | -13,443.9% | – | – | -23,811.9% | 3,681.2% | 115,251.0% | 926.9% | -2,351.0% | 104.7% | -9.8% | |
| – | – | – | – | – | – | 0.0% | – | – | – | -5.4% | – | – | |
| 97,652.3% | – | 61,495.9% | 1,885.5% | – | – | 1,229.1% | 684.3% | 2,156.6% | 422.6% | 3,632.2% | 35.5% | 1,015.1% | |
| 29,838.7% | – | 53,285.5% | -23,499.2% | – | – | -47,084.8% | -3,961.5% | 39,982.5% | -160.1% | 119.3% | -234.3% | 3.0% | |
| -12,959.2% | – | -8,466.9% | -12,180.2% | – | – | -24,845.2% | -8,637.5% | -78,028.7% | -1,515.3% | -1,169.4% | -377.1% | -1,008.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.